Jennifer Doudna

Jennifer is helping Inari optimize CRISPR technology for crop improvement applications. She shares the 2020 Nobel Prize for Chemistry for her work to identify and develop CRISPR-Cas9. She is the Li Ka Shing Chancellor's Professor in Biomedical and Health at the University of California, Berkeley and has been a Howard Hughes Medical Institute (HHMI) Investigator since 1997. Jennifer’s lab studies many aspects of RNA biology and discovered the programmable nature of Cas nucleases. She has received many awards including a Packard Foundation Fellow Award, the American Association for the Advancement of Science Fellow Award and has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, Institute of Medicine of the National Academies and the Royal Society.